{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:27:02Z","timestamp":1786670822140,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Madan Bhandari Academy of Health Sciences, Research Center","award":["Reference number: RC-85, Grant Number S.No. 7"],"award-info":[{"award-number":["Reference number: RC-85, Grant Number S.No. 7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The National Action Plan on antimicrobial resistance (AMR) strategic priority of Nepal focuses on strengthening the surveillance system for the containment of AMR within the country, as such, this study aims to report the prevalence of bacterial isolate and antimicrobial susceptibility pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A hospital-based retrospective cross-sectional study was conducted using routine urine culture and antimicrobial susceptibility records from Hetauda Hospital, Nepal, from May 28, 2023, to September 8, 2023. Clinically significant uropathogens were identified using standard microbiological procedures, and antimicrobial susceptibility testing was performed using the modified Kirby\u2013Bauer disk diffusion method. Susceptibility results were interpreted according to the CLSI M100 criteria used by the hospital laboratory during the study period. Data were analysed descriptively using frequencies, percentages, and relevant denominators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Out of 3893 patient samples, 1162 (29.84%) bacterial isolates were detected. Gram-negative bacteria accounted for 67.81% of the isolates, with\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (47.16%) being the most common, followed by\n                      <jats:italic>Klebsiella sps.<\/jats:italic>\n                      (14.54%). AST has revealed varying patterns across different antibiotics and bacterial species.\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (\n                      <jats:italic>E. coli<\/jats:italic>\n                      ) emerged as the predominant pathogen showing variable susceptibility across antibiotic classes, with highest sensitivity to amikacin (83.90%) and notable resistance to fluoroquinolones and cephalosporins, highlighting significant challenges in empirical therapy. Notably, 20.40% of the isolates were classified as MDR, with\n                      <jats:italic>Proteus vulgaris<\/jats:italic>\n                      showing the highest MDR rate (46.15%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study highlights the prevalence of urinary bacterial isolates (\n                      <jats:italic>E. coli)<\/jats:italic>\n                      and multidrug-resistant strains (\n                      <jats:italic>Proteus vulgaris<\/jats:italic>\n                      ) at Hetauda Hospital, with considerable resistance to cephalosporins and fluoroquinolones. These findings support AST-guided prescribing, local antimicrobial stewardship, and development of a hospital antibiogram. The results are contextually relevant to Nepal\u2019s AMR policy agenda, but they should be interpreted as hospital-level data rather than as provincial or national surveillance estimates.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13781-x","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:03:10Z","timestamp":1780938190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine antibiogram and antimicrobial susceptibility pattern in a provincial hospital of Nepal: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0040-4357","authenticated-orcid":false,"given":"Prashant Kumar","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2014-4339","authenticated-orcid":false,"given":"Sachita","family":"Barma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-5013","authenticated-orcid":false,"given":"Prabhat Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-9122","authenticated-orcid":false,"given":"Biswash","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-5014","authenticated-orcid":false,"given":"Sailendra","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3271-6760","authenticated-orcid":false,"given":"Binita","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0887-3235","authenticated-orcid":false,"given":"Archana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8493-1884","authenticated-orcid":false,"given":"Bishnu","family":"Khakurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8703-6482","authenticated-orcid":false,"given":"Prashant","family":"Bidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8877-2903","authenticated-orcid":false,"given":"Prabin","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1123-2806","authenticated-orcid":false,"given":"Bipindra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"10459","key":"13781_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1.","journal-title":"Lancet"},{"issue":"10442","key":"13781_CR2","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/S0140-6736(24)00862-6","volume":"403","author":"JA Lewnard","year":"2024","unstructured":"Lewnard JA, Charani E, Gleason A, et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet. 2024;403(10442):2439\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(24)00862-6.","journal-title":"Lancet"},{"issue":"2","key":"13781_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","volume":"20","author":"G Sulis","year":"2022","unstructured":"Sulis G, Sayood,Sena, Gandra S. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther. 2022;20(2):147\u201360. https:\/\/doi.org\/10.1080\/14787210.2021.1951705.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"13781_CR4","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/puh2.70034","volume":"4","author":"H Ehsan","year":"2025","unstructured":"Ehsan H. Antibiotic Resistance in Developing Countries: Emerging Threats and Policy Responses. Public Health Chall. 2025;4(1):e70034. https:\/\/doi.org\/10.1002\/puh2.70034.","journal-title":"Public Health Chall"},{"key":"13781_CR5","doi-asserted-by":"publisher","unstructured":"Acharya KP, Wilson RT. Antimicrobial resistance in Nepal. Front Med. 2019;6. https:\/\/doi.org\/10.3389\/fmed.2019.00105.","DOI":"10.3389\/fmed.2019.00105"},{"key":"13781_CR6","unstructured":"National Action Plan on Antimicrobial Resistance. (2024\u20132028), Quality standards and regulation division, ministry of health and population. Accessed March 30, 2025. https:\/\/faolex.fao.org\/docs\/pdf\/NEP229758.pdf"},{"issue":"3","key":"13781_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cll.2019.04.001","volume":"39","author":"KP Smith","year":"2019","unstructured":"Smith KP, Kirby JE. Rapid Susceptibility Testing Methods. Clin Lab Med. 2019;39(3):333\u201344. https:\/\/doi.org\/10.1016\/j.cll.2019.04.001.","journal-title":"Clin Lab Med"},{"key":"13781_CR8","doi-asserted-by":"publisher","first-page":"117562","DOI":"10.1016\/j.trac.2024.117562","volume":"172","author":"M Ramzan","year":"2024","unstructured":"Ramzan M, Raza A, un Nisa Z, et al. Detection of antimicrobial resistance (AMR) and antimicrobial susceptibility testing (AST) using advanced spectroscopic techniques: A review. TrAC Trends Anal Chem. 2024;172:117562. https:\/\/doi.org\/10.1016\/j.trac.2024.117562.","journal-title":"TrAC Trends Anal Chem"},{"issue":"10","key":"13781_CR9","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLOS Med. 2007;4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLOS Med"},{"key":"13781_CR10","unstructured":"Prevention of hospital. -acquired infections: a practical guide. Prevenci\u00f3n de las infecciones nosocomiales: gu\u00eda pr\u00e1ctica \/ revisores: G Ducel, J Fabry y L Nicolle. Published online 2002. Accessed April 17, 2025. https:\/\/iris.who.int\/handle\/10665\/67350"},{"key":"13781_CR11","doi-asserted-by":"publisher","unstructured":"Cheesbrough M. District Laboratory Practice in Tropical Countries. 2nd ed. Cambridge University Press; 2006. https:\/\/doi.org\/10.1017\/CBO9780511543470.","DOI":"10.1017\/CBO9780511543470"},{"key":"13781_CR12","doi-asserted-by":"publisher","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st Edition. J Clin Microbiol. 2021;59(12). https:\/\/doi.org\/10.1128\/jcm.00213-21.","DOI":"10.1128\/jcm.00213-21"},{"issue":"6","key":"13781_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.00203-19","volume":"57","author":"RM Humphries","year":"2019","unstructured":"Humphries RM, Abbott AN, Hindler JA. Understanding and addressing CLSI breakpoint revisions: a primer for clinical laboratories. J Clin Microbiol. 2019;57(6):10\u2013128.","journal-title":"J Clin Microbiol"},{"key":"13781_CR14","doi-asserted-by":"publisher","unstructured":"Bhatta S, Pant PR, Mytton J. Usefulness of hospital emergency department records to explore access to injury care in Nepal. Int J Emerg Med. 2016;9. https:\/\/doi.org\/10.1186\/s12245-016-0120-9.","DOI":"10.1186\/s12245-016-0120-9"},{"issue":"1","key":"13781_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.59779\/jiomnepal.1301","volume":"46","author":"S Kaundinnyayana","year":"2024","unstructured":"Kaundinnyayana S, Chaudhary R, Khadka A, Bhatta S, Rayamajhi H, Sharma M. Antimicrobial Sensitivity among Bacterial Isolates from Sputum Samples in a Tertiary level Hospital. J Inst Med Nepal. 2024;46(1):25\u201330. https:\/\/doi.org\/10.59779\/jiomnepal.1301.","journal-title":"J Inst Med Nepal"},{"issue":"1","key":"13781_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41182-021-00313-3","volume":"49","author":"A Shilpakar","year":"2021","unstructured":"Shilpakar A, Ansari M, Rai KR, Rai G, Rai SK. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. Trop Med Health. 2021;49(1):23. https:\/\/doi.org\/10.1186\/s41182-021-00313-3.","journal-title":"Trop Med Health"},{"key":"13781_CR17","doi-asserted-by":"publisher","first-page":"117863612211507","DOI":"10.1177\/11786361221150761","volume":"16","author":"M Pariyar","year":"2023","unstructured":"Pariyar M, Adhikari S, Regmi RS, et al. Beta-Lactamase-Producing Gram-Negative Bacterial Isolates Among the Patients Attending a Tertiary Care Hospital, Kathmandu, Nepal. Microbiol Insights. 2023;16:11786361221150761. https:\/\/doi.org\/10.1177\/11786361221150761.","journal-title":"Microbiol Insights"},{"issue":"277","key":"13781_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.31729\/jnma.8747","volume":"62","author":"R Chaudhary","year":"2024","unstructured":"Chaudhary R, Bhatta S, Pant C, Phuyal N, Shrestha L. Multidrug Resistance Gram-negative Bacteria in Intensive Care Unit of Tertiary Care Hospital: A Descriptive Cross-sectional Study. J Nepal Med Assoc. 2024;62(277):582\u20136. https:\/\/doi.org\/10.31729\/jnma.8747.","journal-title":"J Nepal Med Assoc"},{"issue":"2","key":"13781_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/tropicalmed6020056","volume":"6","author":"BR Raghubanshi","year":"2021","unstructured":"Raghubanshi BR, Sagili KD, Han WW, et al. Antimicrobial Resistance among Neonates with Bacterial Sepsis and Their Clinical Outcomes in a Tertiary Hospital in Kathmandu Valley, Nepal. Trop Med Infect Dis. 2021;6(2):56. https:\/\/doi.org\/10.3390\/tropicalmed6020056.","journal-title":"Trop Med Infect Dis"},{"issue":"10","key":"13781_CR20","doi-asserted-by":"publisher","first-page":"e0223409","DOI":"10.1371\/journal.pone.0223409","volume":"14","author":"HQ Nguyen","year":"2019","unstructured":"Nguyen HQ, Nguyen NTQ, Hughes CM, O\u2019Neill C. Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study. PLoS ONE. 2019;14(10):e0223409. https:\/\/doi.org\/10.1371\/journal.pone.0223409.","journal-title":"PLoS ONE"},{"issue":"10","key":"13781_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/antibiotics13100966","volume":"13","author":"AL Golli","year":"2024","unstructured":"Golli AL, Popa SG, Cara ML, Stoica GA, Fortofoiu D, Stoica M. Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic. Antibiotics. 2024;13(10):966. https:\/\/doi.org\/10.3390\/antibiotics13100966.","journal-title":"Antibiotics"},{"issue":"1","key":"13781_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13756-016-0168-6","volume":"6","author":"NP Parajuli","year":"2017","unstructured":"Parajuli NP, Maharjan P, Parajuli H, et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control. 2017;6(1):9. https:\/\/doi.org\/10.1186\/s13756-016-0168-6.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13781_CR23","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1186\/s12879-025-12074-z","volume":"25","author":"S Karna","year":"2025","unstructured":"Karna S. Burden of antibiotic resistance in urinary isolates: a retrospective cross-sectional study from a tertiary center in Far-Western Nepal. BMC Infect Dis. 2025;25:1634. https:\/\/doi.org\/10.1186\/s12879-025-12074-z.","journal-title":"BMC Infect Dis"},{"key":"13781_CR24","doi-asserted-by":"publisher","unstructured":"Adhikari J, Thapaliya S, Munakarmi R, Acharya P, Basnet HB, Paudyal N. Drivers and patterns of antibiotic use in small to medium-sized chicken farms in selected districts of Nepal. Front Vet Sci. 2025;12. https:\/\/doi.org\/10.3389\/fvets.2025.1570822.","DOI":"10.3389\/fvets.2025.1570822"},{"issue":"1","key":"13781_CR25","doi-asserted-by":"publisher","first-page":"11554","DOI":"10.1038\/s41598-021-90812-4","volume":"11","author":"KR Rijal","year":"2021","unstructured":"Rijal KR, Banjara MR, Dhungel B, et al. Use of antimicrobials and antimicrobial resistance in Nepal: a nationwide survey. Sci Rep. 2021;11(1):11554. https:\/\/doi.org\/10.1038\/s41598-021-90812-4.","journal-title":"Sci Rep"},{"key":"13781_CR26","unstructured":"National Antimicrobial Treatment Guideline. 2023, Ministry of Health & Population of Nepal. Accessed March 30, 2025. https:\/\/mohp.gov.np\/content\/149\/national-antimicrobial-treatment-guideline-2023\/"},{"issue":"9","key":"13781_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cmi.2022.03.014","volume":"28","author":"G Sulis","year":"2022","unstructured":"Sulis G, Sayood S, Katukoori S, et al. Exposure to World Health Organization\u2019s AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(9):1193\u2013202. https:\/\/doi.org\/10.1016\/j.cmi.2022.03.014.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"13781_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12962-021-00263-x","volume":"19","author":"Z Saleem","year":"2021","unstructured":"Saleem Z, Saeed H, Akbar Z, et al. WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan. Cost Eff Resour Alloc. 2021;19(1):10. https:\/\/doi.org\/10.1186\/s12962-021-00263-x.","journal-title":"Cost Eff Resour Alloc"},{"issue":"11","key":"13781_CR29","doi-asserted-by":"publisher","first-page":"e0294644","DOI":"10.1371\/journal.pone.0294644","volume":"18","author":"N Jha","year":"2023","unstructured":"Jha N, Thapa B, Pathak SB, Kafle S, Mudvari A, Shankar PR. Availability of access, watch, and reserve (AWaRe) group of antibiotics in community pharmacies located close to a tertiary care hospital in Lalitpur, Nepal. PLoS ONE. 2023;18(11):e0294644. https:\/\/doi.org\/10.1371\/journal.pone.0294644.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13781-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:36:56Z","timestamp":1786667816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13781-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13781"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13781-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained prior to the commencement of the study from the Institutional Review Committee of MBAHS (IRC-MBAHS Approval number IRC-024-079). Data collection approval letter was obtained from the study cite. Written and verbal informed consent was taken before the commencement of the data collection. Privacy and confidentiality of information obtained from patient records were maintained by coding data instead of using personal identifiers. All study procedure was implementated in accordance with national regulations and the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1488"}}